IFIH1 and dermatomyositis: As the initial treatment of RPILD with anti-MDA5 Ab-positive DM patients, the combination of corticosteroids, cyclophosphamide, and calcineurin inhibitor is recommended.[29] However, there are no established treatment guidelines for the prevention of recurrence during remission.